Trial Profile
Does atorvastatin reduce ischemia-reperfusion injury in humans in-vivo?
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Cardiovascular disorders; Reperfusion injury
- Focus Therapeutic Use
- Acronyms ator
- 24 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Oct 2008 Planned end date changed from 1 Jun 2007 to 1 Dec 2008 as reported by ClinicalTrials.gov.
- 30 Jul 2007 Status changed from recruiting to completed.